[1] |
WU L, PEI F, MEN X, et al. MiR-329 inhibits papillary thyroid cancer progression via direct targeting WNT1[J]. Oncol Lett, 2018, 16(3):3561-3568.
|
[2] |
XIONG Y, KOTIAN S, ZEIGER M A, et al. MiR-126-3p inhibits thyroid cancer cell growth and metastasis,and is associated with aggressive thyroid cancer[J]. PLoS One, 2015, 10(8):e0130496.
|
[3] |
LI P, DONG M, WANG Z. Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer(PTC)[J]. Bosn J Basic Med Sci, 2019, 19(2):146-154.
|
[4] |
WU X, DAI L, ZHANG Z, et al. Overexpression of microRNA-203 can downregulate survivin and function as a potential therapeutic target in papillary thyroid cancer[J]. Oncol Lett, 2020, 19(1):61-68.
|
[5] |
SUI G Q, FEI D, GUO F, et al. MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3[J]. Am J Cancer Res, 2017, 7(5):1177-1187.
|
[6] |
QU N, HU J Q, LIU L, et al. SIRT6 is upregulated and associated with cancer aggressiveness in papillary thyroid cancer via BRAF/ERK/Mcl1 pathway[J]. Int J Oncol, 2017, 50(5):1683-1692.
|
[7] |
SIPOS J A, MAZZAFERRI E L. Thyroid cancer epidemiology and prognostic variables[J]. Clin Oncol(R Coll Radiol), 2010, 22(6):395-404.
|
[8] |
MISIAK D, BAUER M, LANGE J, et al. MiRNA deregulation distinguishes anaplastic thyroid carcinoma(atc) and supports upregulation of oncogene expression[J]. Cancers(Basel), 2021, 13(23):5913.
|
[9] |
YANG H, ZHU R, ZHAO X, et al. Sirtuin-mediated deacetylation of hnRNP A1 suppresses glycolysis and growth in hepatocellular carcinoma[J]. Oncogene, 2019, 38(25):4915-4931.
|
[10] |
曾勇, 郑克思, 陈聪, 等. HIF-1α和SIRT6在甲状腺癌组织中的表达及其与肿瘤血管生成的关系[J]. 中国高等医学教育, 2019, 33(12):137.
|
[11] |
ZOU T, DUAN J, LIANG J, et al. MiR-338-3p suppresses colorectal cancer proliferation and progression by inhibiting MACC1[J]. Int J Clin Exp Pathol, 2018, 11(4):2256-2267.
|
[12] |
ZHANG C, LI H, WANG J, et al. MicroRNA-338-3p suppresses cell proliferation,migration and invasion in human malignant melanoma by targeting MACC1[J]. Exp Ther Med, 2019, 18(2):997-1004.
|
[13] |
ZHANG R, SHI H, REN F, et al. MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis:implication of Wnt/catenin beta and MEK/ERK signaling pathways[J]. J Exp Clin Cancer Res, 2019, 38(1):494.
|
[14] |
MITTAL V. Epithelial mesenchymal transition in tumor metastasis[J]. Annu Rev Pathol, 2018,13:395-412.
|
[15] |
KUPHAL S, BOSSERHOFF A K. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma[J]. Oncogene, 2006, 25(2):248-259.
|
[16] |
COULOMBE P A, WONG P. Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds[J]. Nat Cell Biol, 2004, 6(8):699-706.
|
[17] |
SCANLON C S, VAN TUBERGEN E A, INGLEHART R C, et al. Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma[J]. J Dent Res, 2013, 92(2):114-121.
|
[18] |
马涛, 李丹, 杨翠宏. 卵巢癌组织中miR-338-3p、MACC1的表达变化及意义[J]. 山东医药, 2020, 60(16):18-21.
|